Aytu Bioscience Inc (NASDAQ:AYTU) Just Reported Increased Shorts

May 17, 2018 - By Larry Purdy

The stock of Aytu Bioscience Inc (NASDAQ:AYTU) registered an increase of 12.74% in short interest. AYTU’s total short interest was 299,100 shares in May as published by FINRA. Its up 12.74% from 265,300 shares, reported previously. With 2.87M shares average volume, it will take short sellers 0 days to cover their AYTU’s short positions. The short interest to Aytu Bioscience Inc’s float is 14.86%.

The stock increased 3.63% or $0.014 during the last trading session, reaching $0.4. About 932,975 shares traded. Aytu BioScience, Inc. (NASDAQ:AYTU) has declined 96.00% since May 17, 2017 and is downtrending. It has underperformed by 107.55% the S&P500.

Aytu BioScience, Inc., a specialty healthcare company, focuses on developing and commercializing novel products in the field of urology in the United States. The company has market cap of $14.35 million. The firm markets Natesto for the treatment of hypogonadism in men; and ProstaScint for use in newly diagnosed high-risk prostate cancer patients and patients with recurrent prostate cancer. It currently has negative earnings. It is also involved in commercializing of the RedoxSYS System for research use in various applications.

Another recent and important Aytu BioScience, Inc. (NASDAQ:AYTU) news was published by Benzinga.com which published an article titled: “Benzinga’s Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway” on May 15, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.